Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1267 of 5804
-
First-in-Human trial launches for targeted radiation therapy against FAP-Expressing tumors
Disease control OngoingThis first-in-human study aimed to assess the safety and internal radiation dosimetry of 177Lu-JH040182, a novel FAP-targeted radiopharmaceutical, in patients with FAP-positive tumors. All patients underwent screening via 68Ga-FAPI PET/CT. Those confirmed to have FAP-positive les…
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
5-Day radiation before sarcoma surgery could spare healthy tissue
Disease control Recruiting nowThe purpose of this research study is to preserve healthy tissue around the cancer on the arm(s) and/or leg(s) using Hypofractionated radiotherapy, while treating the cancer and preventing it from spreading to other areas of the body.
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
15,000 kids to be screened for hidden heart disease genes
Knowledge-focused Recruiting nowChild-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screen…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New drug shows promise for slowing kidney disease in Non-Diabetic patients
Disease control CompletedThis study aims to assess the effect of finerenone on proteinuria and GFR progression in patients with non-diabetic glomerulonephritis.
Phase: PHASE2 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Culturally tailored questionnaire aims to boost advance care planning in indigenous communities
Knowledge-focused Recruiting nowThe older Alaska Native/American Indian (ANAI) population is increasing at twice the rate of the general population with a higher burden of serious illness. Older ANAI adults with serious illness are half as likely to have advance directives (AD), indicating a need for improved a…
Phase: NA • Sponsor: Southcentral Foundation • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New hope for tough cancers: targeted drug trial launches
Disease control Recruiting nowThis study is a multi-indication, open-label, single-treatment arm, parallel-cohort phase II study of enfortumab vedotin in adult participants with advanced or metastatic colorectal cancer (CRC) or hepatocellular carcinoma (HCC) who have been previously treated with one or more l…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can fasting and exercise tame metabolic syndrome? new saudi trial aims to find out
Disease control Recruiting nowMetabolic syndrome (MetS) is a global health issue defined by a cluster of risk factors-abdominal obesity, elevated blood pressure, high fasting blood sugar, high triglycerides, and low HDL cholesterol-that together significantly increase the risk of cardiovascular disease, type …
Phase: NA • Sponsor: Universiti Putra Malaysia • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control ENROLLING_BY_INVITATIONThis study is a Phase 3 extension, global, multicenter open-label study. The purpose of this study is to evaluate long-term safety and efficacy of riliprubart in adult participants with chronic inflammatory demyelinating polyneuropathy (CIDP) who have completed Part B in 1 of 3 p…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Robots vs electricity vs therapy: which best restores hand movement after spinal injury?
Symptom relief Completed2\. Purpose and Significance of the Study (Primary and Secondary Objectives, if any) Spinal cord injury (SCI) is a clinical condition characterized by partial or total loss of motor, sensory, and autonomic functions below the level of the lesion, depending on the severity and lev…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Brain zaps tailored just for you: new study aims to beat chronic pain
Symptom relief Recruiting nowPrevious research has shown the effectiveness of magnetic stimulation of the brain as a supplemental treatment for various conditions, such as depression and chronic pain. However, the application of magnetic stimulation has been standardized across patients without considering i…
Phase: NA • Sponsor: Aalborg University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
AI beats the clock: new platform could speed up heart attack diagnosis
Diagnosis CompletedThe ASSIST clinical study is an observational, multicenter study to assess the performance of a cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, developed to detect Acute Myocardial Infarction (AMI). The main objectives are to compare Willem™ …
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Could a common cough medicine protect the heart during a heart attack?
Disease control CompletedPrimary percutaneous coronary intervention (PCI) is the gold standard for reperfusion therapy in patients with ST-elevation myocardial infarction (STEMI), as it restores blood flow by clearing the blocked coronary artery. This process helps reoxygenate the previously hypoxic myoc…
Phase: PHASE2 • Sponsor: dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Heart stent breakthrough: cameras inside arteries could save thousands
Disease control Recruiting nowCoronary artery disease remains a leading cause of mortality worldwide and is commonly treated with percutaneous coronary intervention (PCI). Typically, PCI is guided by invasive coronary angiography (ICA). However, ICA has inherent limitations in accurately assessing vessel dime…
Sponsor: Cathreine BV • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to shrink lymphoma tumors in untreated patients
Disease control Recruiting nowThis is a prospective, single-arm, phase II study aimed at evaluating the safety and efficacy of orelabrutinib combined with rituximab ± lenalidomide in response-adapted stratified therapy for untreated marginal zone lymphoma. The primary endpoint is the complete response rate (C…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Genetic test aims to get vets on statins and cut heart risk
Disease control Recruiting nowStatins are the most cost-effective medications to lower cholesterol and cardiovascular disease (CVD) risk. However, many patients at high-risk for CVD do not accept or adhere to statins. This gap in patient's use of statins limits the full impact of these effective medications r…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug aims to prevent Crohn's relapse after surgery
Prevention Recruiting nowMAINTAIN-POP is a Phase 2, randomised, double-blind, placebo-controlled, multicenter study of the impact of oral administration of EXL01 in the prevention of post-operative endoscopic recurrence of Crohn's disease after surgery. Approximately 80 eligible patients will be randomi…
Phase: PHASE2 • Sponsor: Madeleine Bezault • Aim: Prevention
Last updated Jun 26, 2026 17:44 UTC
-
Pregnant women with hepatitis b: which drug is safer?
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to study the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy with chronic hepatitis B.
Phase: PHASE4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Zapping pancreatic tumors with heat: a Needle-Sized hope
Disease control Recruiting nowTranscutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment o…
Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main questions it aims to answer are: Is NDI-219216 safe and what kinds of side effect…
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for depression in spinal cord injury: brain stimulation without hand movement
Symptom relief Recruiting nowDepression is a leading cause of disability worldwide and is more commonly seen in individual's post-spinal cord injury (SCI) than in the general population. Depression post-SCI impacts an individuals' quality of life and recovery. It has been reported that among Veterans with an…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC